Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
M412317-5mg | 5mg | In stock | $162.90 | |
M412317-25mg | 25mg | In stock | $733.90 | |
M412317-100mg | 100mg | In stock | $2,640.90 | |
M412317-250mg | 250mg | In stock | $5,941.90 |
Peroxidases Inhibitors
Specifications & Purity | Moligand™, ≥98% |
---|---|
Biochemical and Physiological Mechanisms | MPO-IN-28 (Compound 28) is an inhibitor of myeloperoxidase (MPO) with IC50 of 44 nM. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of myeloperoxidase |
Product Description | Information MPO-IN-28 MPO-IN-28 (Compound 28) is an inhibitor of myeloperoxidase (MPO) with IC50 of 44 nM. Targets MPO (Cell-free assay) 44 nM |
ALogP | 1.14 |
---|---|
HBD Count | 2 |
Rotatable Bond | 2 |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 2-(7-methoxy-4-methylquinazolin-2-yl)guanidine |
---|---|
INCHI | InChI=1S/C11H13N5O/c1-6-8-4-3-7(17-2)5-9(8)15-11(14-6)16-10(12)13/h3-5H,1-2H3,(H4,12,13,14,15,16) |
InChi Key | ZJBMSSBTCGJZEE-UHFFFAOYSA-N |
Canonical SMILES | CC1=C2C=CC(=CC2=NC(=N1)N=C(N)N)OC |
Isomeric SMILES | CC1=C2C=CC(=CC2=NC(=N1)N=C(N)N)OC |
PubChem CID | 2835211 |
MeSH Entry Terms | 2-(7-methoxy-4-methylquinazolin-2-yl)guanidine |
Molecular Weight | 231.25 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
J2214624 | Certificate of Analysis | Jun 17, 2022 | M412317 |
J2214625 | Certificate of Analysis | Jun 17, 2022 | M412317 |
J2214626 | Certificate of Analysis | Jun 17, 2022 | M412317 |
J2214628 | Certificate of Analysis | Jun 17, 2022 | M412317 |
Solubility | Solubility (25°C) In vitro DMSO: 46 mg/mL (198.91 mM); Water: Insoluble; Ethanol: Insoluble; |
---|---|
DMSO(mg / mL) Max Solubility | 46 |
DMSO(mM) Max Solubility | 198.918918918919 |
Water(mg / mL) Max Solubility | <1 |
1. Soubhye J, Chikh Alard I, Aldib I, Prévost M, Gelbcke M, De Carvalho A, Furtmüller PG, Obinger C, Flemmig J, Tadrent S et al.. (2017) Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.. J Med Chem, 60 (15): (6563-6586). [PMID:28671460] |